Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-lasting complete remission with tyrosine kinase inhibitor in bronchioloalveolar carcinoma with a so far unknown EGFR mutation.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Apr 2008

Ludovini Vienna, Gori Stefania, Pistola Lorenza, Della Fazia Maria Agnese, Piobbico Danilo, Servillo Giuseppe, Flacco Antonella, Scuderi Cristina, Crinò Lucio

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Bronchiolo-Alveolar
Share to Antineoplastic Combined Chemotherapy Protocols
Share to Cisplatin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Deoxycytidine

Share to Gemcitabine

Share to Immunoenzyme Techniques

Share to Protein-Tyrosine Kinases

Share to Remission Induction

Source

Identifiers

PMID: 18379371
DOI: 10.1097/JTO.0b013e318169e341

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Long-lasting complete remission with tyrosine kinase inhibitor in bronchioloalveolar carcinoma with a so far unknown EGFR mutation.PMID 18379371Read ↗

Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer.Semantic proximity Read ↗

Impressive Response to Tyrosine Kinase Inhibitors in a Patient with Respiratory Failure for EGFR-Mutated Metastatic Lung Cancer.Semantic proximity Read ↗

Successful Treatment of Non-Small Cell Lung Cancer With Erlotinib Throughout Pregnancy.Semantic proximity Read ↗

Long-term response to gefitinib and crizotinib in lung adenocarcinoma harboring both epidermal growth factor receptor mutation and EML4-ALK fusion gene.Semantic proximity Read ↗

Bronchioloalveolar carcinoma: a translational perspective.Semantic proximity Read ↗

A 75-year-old man with progressive bronchioalveolar carcinoma.Semantic proximity Read ↗

Epidermal growth factor receptor inhibition in lung cancer: status 2012.Semantic proximity Read ↗

Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic Oncology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.